Answers are grounded in this paper and cite their sources.
Participant-collected dried blood spots (DBS), which can be returned using regular mail, are convenient for collecting samples for population serology studies. The impact of DBS sampling on assay performance remains unclear. We estimated the impact of using DBS samples on estimates of population SARS-CoV-2 antibody levels within a study of older Canadians. Analyzing data from 3,796 participants who provided DBS samples and 3,457 participants who provided venous samples, we estimated the impact of sample collection modality on odds of testing positive for anti-nucleocapsid antibodies (Anti-N) or for antibodies to the SARS-CoV-2 spike protein (Anti-S) using the Elecsys Anti-SARS-CoV-2 and Anti-SARS-CoV-2 S immunoassays. We used inverse probability of treatment weighting to control for differences between participants who provided DBS or venous samples, including sample collection date and participants’ age, vaccination status, and geographic location. Compared to venous samples, DBS samples were less likely to be Anti-N positive (weighted risk ratio [RR]: 0.30, 95% confidence interval [CI]: 0.25–0.36) and less likely to be Anti-S positive (RR: 0.83, 95% CI: 0.80–0.86). We estimate that using DBS for all participants would have underestimated seropositivity for anti-N antibodies (2.48% using DBS; 8.32% using venous) and anti-S antibodies by (42.7% using DBS; 51.6% using venous). In population serology studies, DBS samples should only be used instead of venous blood draws when the impact on assay performance is well-characterized and appropriate adjustments are used to derive population seropositivity estimates.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: